What you have unwittingly described is the very reason we should be excited. As the company continues to show optimism that all you stated should happen this year, it only compresses the timeline. It means the catalysts are going to come fast and often. It means huge gains before the end of the year. An unstoppable tsunami of great news.
Unless your pessimism is accurate, and none of this will happen this year. IMO you are greatly mistaken. But I've been wrong before, and will likely be again.
17"...The trials rules are being redone as we speak for studies with certain (TBD-IMO) prerequisites and criteria. We cannot predict the format/protocols and criteria that will be used, although we have some hints that timelines will probably change. IMO, the emphasis will shift from heavy on stats and n to heavy on science and understanding pass criteria. There will be fewer/maybe no pass/fail trials if they do it right but more learning from trials. How results are reported may be different...all IMO.
News 
Market Data 
Discover 
